Business

Philips intends to extend maturity of forward purchases of 4 million shares for long-term incentive plans

September 15, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) announces today that it intends to extend the settlement of two forward contracts for 2 million long-term incentive plans shares each as part of the share repurchase program earlier announced on June 14, 2023. The planned extension will postpone the original maturity dates in Q4 2025 by one year to a new maturity date in Q4 2026. Further details will be available via this link. For further information, please co

articleKoninklijke Philips N.v.September 15, 20252/company/koninklijke-philips-nv-1/news/philips-intends-to-extend-maturity-of-forward-purchases-of-4-million-shares-for-long-term-incentive-plans-1
Philips intends to extend maturity of forward purchases of 4 million shares for long-term incentive plans

About this update from Koninklijke Philips N.v.

[{"type":"image","alt":"Royal Philips","displaySize":"","headline":null,"caption":"Royal Philips","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":55,"url":"https://media.zenfs.com/en/globenewswire.com/e89b2492268f247076ffcde3cdf98919"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/gAicZ00NXenNt1pULlYKVg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTc3O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/e89b2492268f247076ffcde3cdf98919","width":300,"height":55}},"lazy":false},{"type":"text","content":"September 15, 2025","length":18,"tagName":"p"},{"type":"text","content":"Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) announces today that it intends to extend the settlement of two forward contracts for 2 million long-term incentive plans shares each as part of the share repurchase program earlier announced on June 14, 2023. The planned extension will postpone the original maturity dates in Q4 2025 by one year to a new maturity date in Q4 2026. Further details will be available via this link.","length":451,"tagName":"p"},{"type":"text","content":"For further information, please contact:Michael FuchsPhilips Global External RelationsTel.: +31 6 1486 9261E-mail: [email protected]","length":144,"tagName":"p"},{"type":"text","content":"Dorin DanuPhilips Investor RelationsTel.: +31 20 59 77055E-mail: [email protected]","length":90,"tagName":"p"},{"type":"text","content":"About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.","length":854,"tagName":"p"},{"type":"text","content":"Forward-looking statementsThis...

More updates from Koninklijke Philips N.v.

Royal PhilipsForward-looking statementsmaturity date